National Peroxide Share Price
634.00+7.75 (+1.24%)
+1.73% past 1 Year
National Peroxide (NPL) is a public limited Company established in 1954. It is also certified for ISO 9001 Quality Management System, ISO 14001 Environmental Management System, ISO 45001 Occupational Health
Corporate filings & documents
Announcements
Please find attached herewith communication sent to the Shareholders pertaining to Notice of 6th Annual General Meeting along with Annual Report for FY 25-26
19 hours agoPlease find attached herewith communication sent to the Shareholders pertaining to Notice of 6th Annual General Meeting along with Annual Report for FY 25-26
19 hours agoPlease find attached herewith Notice of 6th Annual General Meeting of the Company along with Annual Report for FY 2025-26.
19 hours agoPlease find attached herewith Notice of 6th Annual General Meeting of the Company along with Annual Report for FY 2025-26.
19 hours agoPlease find attached herewith Annual Report of the Company for FY 2025-26 along with Notice of 6th Annual General meeting.
19 hours agoPlease find attached herewith Annual Report of the Company for FY 2025-26 along with Notice of 6th Annual General meeting.
19 hours agoPlease find enclosed herewith Newspaper Publication regarding Annual General meeting of the Company.
2 days agoPlease find enclosed herewith Newspaper Publication regarding Annual General meeting of the Company.
2 days agoPlease find attached Copies of Newpaper Publication of the Extract of the Revised Audited Financial Results for the Quarter & year ended March 31 2026 and Unaudited Financial results for the Quarter ended June 30 2026.
3 weeks agoPlease find attached Copies of Newpaper Publication of the Extract of the Revised Audited Financial Results for the Quarter & year ended March 31 2026 and Unaudited Financial results for the Quarter ended June 30 2026.
3 weeks agoThe Board of Directors at its meeting held on April 30 2026 had recommend the final dividend 70% being Rs. 7 per equity share of Rs. 10 each for the financial year ended March 31 2026. The recommendation remains unchanged and is subject to approval of the members at the ensuing Annual General meeting.
3 weeks agoThe Board of Directors at its meeting held on April 30 2026 had recommend the final dividend 70% being Rs. 7 per equity share of Rs. 10 each for the financial year ended March 31 2026. The recommendation remains unchanged and is subject to approval of the members at the ensuing Annual General meeting.
3 weeks agoPlease find details of Book Closure of dates for Annual General meeting.
3 weeks agoPlease find details of Book Closure of dates for Annual General meeting.
3 weeks agoPlease find attached herewith details of Annual general Meeting of the Company.
3 weeks agoPlease find attached herewith details of Annual general Meeting of the Company.
3 weeks agoThe Board has in its meeting held August 12 2026 has recommended the reappointment of the Statutory Auditor of the Company.
3 weeks agoThe Board has in its meeting held August 12 2026 has recommended the reappointment of the Statutory Auditor of the Company.
3 weeks agoPlease find attached herewith unaudited financial results for quarter ended June 30 2026
3 weeks agoPlease find attached herewith unaudited financial results for quarter ended June 30 2026
3 weeks agoPlease find attached herewith Revised Financial results for the quarter and year ended March 31 2026
3 weeks agoPlease find attached herewith Revised Financial results for the quarter and year ended March 31 2026
3 weeks agoThis is to inform you that the Board of Directors of the Company at their meeting held today i.e. on Wednesday August 12 2026 have inter-alia considered and approved the following: 1. Statement of Revised Audited Financial Results & Revised Audit Report for the quarter and financial year ended March 31 2026 ; 2. Unaudited Financial Results for the quarter ended June 30 2026 and other matters
3 weeks agoThis is to inform you that the Board of Directors of the Company at their meeting held today i.e. on Wednesday August 12 2026 have inter-alia considered and approved the following: 1. Statement of Revised Audited Financial Results & Revised Audit Report for the quarter and financial year ended March 31 2026 ; 2. Unaudited Financial Results for the quarter ended June 30 2026 and other matters
3 weeks agoThis is to inform you that the Board of Directors of the Company at their meeting held today i.e. on Wednesday August 12 2026 have inter-alia considered and approved the following: 1. Statement of Revised Audited Financial Results & Revised Audit Report for the quarter and financial year ended March 31 2026 ; 2. Unaudited Financial Results for the quarter ended June 30 2026 and other matters
3 weeks agoThis is to inform you that the Board of Directors of the Company at their meeting held today i.e. on Wednesday August 12 2026 have inter-alia considered and approved the following: 1. Statement of Revised Audited Financial Results & Revised Audit Report for the quarter and financial year ended March 31 2026 ; 2. Unaudited Financial Results for the quarter ended June 30 2026 and other matters
3 weeks agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve i. Revised Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 and Revised Audited Financial Statements for the financial year ended March 31 2026 ii. Un-audited Financial Results of the Company for the quarter ended June 30 2026;
3 weeks agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve i. Revised Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 and Revised Audited Financial Statements for the financial year ended March 31 2026 ii. Un-audited Financial Results of the Company for the quarter ended June 30 2026;
3 weeks agoThe Board Meeting to be held on 03/08/2026 Stands Cancelled.
1 month agoThe Board Meeting to be held on 03/08/2026 Stands Cancelled.
1 month agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve Unaudited Financial Results for quarter ended 30th June 2026.
1 month agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve Unaudited Financial Results for quarter ended 30th June 2026.
1 month agoPlease find attached resignation of Chief Information Officer of the Company.
1 month agoPlease find attached resignation of Chief Information Officer of the Company.
1 month agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026 is enclosed herewith.
1 month agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026 is enclosed herewith.
1 month agoThe Company has informed the Stock Exchange about the closure of Trading window.
2 months agoThe Company has informed the Stock Exchange about the closure of Trading window.
2 months agoPlease find attached Annual Secretarial Compliance Report of the Company for financial year ended March 31 2026
3 months agoPlease find attached clipping of Newspaper Publication.
4 months agoPlease find attached Financial Results.
4 months agoPlease find attached Financial Results.
4 months agoThe Company hereby informs that The Board of Directors in its meeting held on April 30 2026 has approved the appointment of Chief Financial Officer of the Company
4 months agoThe Company hereby informs that The Board of Directors in its meeting held on April 30 2026 has approved the appointment of Chief Financial Officer of the Company
4 months agoThe Company hereby informs the Exchange that Mr. Amit Goriwale has step down from the position of Interim Chief Financial Officer of the Company from close of business hours May 31 2026
4 months agoPlease find enclosed Board Meeting Outcome contains details of Dividend
4 months agoThis is to inform you that the Board of Directors of National Peroxide Limited at their meeting held today i.e. on April 30 2026 had inter-alia considered and approved the following items of business:1. Statement of Audited Financial Results for the quarter and financial year ended March 31 20262. Recommendation of the Dividend3. Change in Key Managerial Personnel of the Company:
4 months agoThis is to inform you that the Board of Directors of National Peroxide Limited at their meeting held today i.e. on April 30 2026 had inter-alia considered and approved the following items of business:1. Statement of Audited Financial Results for the quarter and financial year ended March 31 20262. Recommendation of the Dividend3. Change in Key Managerial Personnel of the Company:
4 months agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 and to recommend dividend if any for the financial year ended March 31 2026.
4 months agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2026 inter alia to consider and approve the Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 and to recommend dividend if any for the financial year ended March 31 2026.
4 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
2026-09-22
Dividend
7.0
2024-08-20
Dividend
12.5
Company details
Registered office
Neville House J N Heredia Marg Ballard Estate Mumbai Maharashtra PIN: 400001 Tel No: 022-66620000 Fax No: NULL Email: [email protected] Internet: www.naperol.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Ness N Wadia, Chairman
Minnie Bodhanwala, Non Independent & Non Executive Director
Viraf Mehta, Non Executive Independent Director
Parvathi Menon, Non Executive Independent Director
Jaivir Singh, Non Executive Independent Director
Rajiv Arora, Whole Time Director & Chief Executive Officer
Akshay Satasiya, Company Secretary & Compliance Officer
Details
BSE 544205
NSE NULL
ISIN INE0PO601011